Avecho Biotechnology Ltd

AVE

Company Profile

  • Business description

    Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.

  • Contact

    Unit A8, 2A Westall Road
    Clayton
    MelbourneVIC3168
    AUS

    T: +61 390025000

    https://www.avecho.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    34

Stocks News & Analysis

stocks

Are we as bullish on Oracle as the market?

Shares jumped in response to the latest results.
stocks

Anglo American strikes deal to create a new copper giant

We are surprised that Teck agreed to the merger on these terms, and wouldn’t be surprised if there is a twist in the tale.
stocks

The ‘other’ AI chip behemoth that might just be getting started

The magnitude of growth at Broadcom continues to astound us.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,063.6016.90-0.19%
CAC 407,761.3211.930.15%
DAX 4023,632.9585.50-0.36%
Dow JONES (US)45,490.92220.42-0.48%
FTSE 1009,225.3917.14-0.19%
HKSE26,065.12135.14-0.52%
NASDAQ21,886.066.570.03%
Nikkei 22544,347.08509.411.16%
NZX 50 Index13,229.1547.09-0.35%
S&P 5006,532.0419.430.30%
S&P/ASX 2008,796.9016.90-0.19%
SSE Composite Index3,856.5644.341.16%

Market Movers